Acudx Inc

AcuDX is developing the world’s first handheld digital PCR System for genomic testing. Performing at comparable level of sensitivity and specificity, our device is much less in size and cost, vs. digital PCR machines on the market. It is easy to operate and test results are available in 30-60 minutes. This disruptive platform technology can be a powerful tool for genomic testing of cancer and other infectious viruses including HBV, HPV and Covid-19. It can be adopted quickly by researchers, hospitals & clinics and Point-of Care Testing (POCT). It can democratize the molecular diagnostics market, and has the potential to become the first consumer genetic testing device for at-home use.